Form 4: Aardvark Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Zhongwei Zhang, a Director of Aardvark Therapeutics, Inc., received 127,061 shares of common stock on October 7, 2026.
Summary
- Grant/award: acquired 127,061 Stock Option (right to buy) on October 7, 2026; holds 127,061 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Zhongwei Zhang — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-07 | Grant/award | Stock Option (right to buy) | 127,061 | — | — | 127,061 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-07 | Grant/award (127,061 shares) |
Keywords
insider transaction, Form 4, AARD, Aardvark Therapeutics, Inc., neutral, Zhongwei Zhang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.